NKF KDOQI GUIDELINES

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease (2006)

Tables
Figures
Abbreviations and Acronyms
Work Group Membership
KDOQI Advisory Board Members
Foreword

• I: Executive Summary
• II: Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease in Adults
  • 1.1. Identifying Patients and Initiating Evaluation
  • 1.2. Evaluation of Anemia in CKD
  • 2.1. Hb Range
  • 3.1. Using ESAs
  • 3.2. Using Iron Agents
  • 3.3. Using Pharmacological and Nonpharmacological Adjuvants to ESA Treatment in HD-CKD
  • 3.4. Transfusion Therapy
  • 3.5. Evaluating and Correcting Persistent Failure To Reach or Maintain Intended Hb
• III: Clinical Practice Recommendations for Anemia in Chronic Kidney Disease in Children
  • 1.1. Identifying Patients and Initiating Evaluation
  • 1.2. Evaluation of Anemia in CKD
  • 2.1. Hb Range
  • 3.1. Using ESAs
  • 3.2. Using Iron Agents
  • 3.3. Using Pharmacological and Nonpharmacological Adjuvants to ESA Treatment in HD-CKD
  • 3.4. Transfusion Therapy
  • 3.5. Evaluating and Correcting Persistent Failure To Reach or Maintain Intended Hb Level
• IV: Clinical Practice Recommendations for Anemia in Chronic Kidney Disease in Transplant Recipients
• V:  Appendix 1: Methods of Evidence Review and Synthesis

Work Group Biographies
Acknowledgments
References

Disclaimer